Publications
30
Citations
170
Est. group size
~2
Recurring co-author estimate
Active years
46
Publishing since 1980
Sarah C. Linn's research focuses on how the urinary tract and bladder defend against infection, particularly urinary tract infections (UTIs) caused by uropathogenic E. coli, and how factors like obesity, diabetes, and insulin/PTEN signaling affect susceptibility to these infections and related kidney injury. Some work also involves veterinary case studies and biomarkers for kidney damage (nephrotoxicity) in both animal models and clinical contexts, including cancer treatment side effects. This research combines molecular immunology, kidney/bladder physiology, and translational veterinary medicine.
Publication output has grown over the past decade, rising from occasional papers before 2021 to a steady rate of about 5 publications per year from 2022 through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Obesity promotes urinary tract infection by disrupting bladder focal adhesion kinase signaling
iScience · 2025
- Obesity promotes urinary tract infection by disrupting urothelial immune defenses
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Crusting pastern dermatitis in a 15-year-old warmblood gelding
Journal of the American Veterinary Medical Association · 2025
- PTEN modulates urinary tract infection susceptibility and shapes urothelial antibacterial defenses
Life Science Alliance · 2025
- Evaluation of symmetric dimethylarginine as a renal biomarker in zoo-housed red pandas (Ailurus fulgens spp)
American Journal of Veterinary Research · 2025
- Insulin receptor signaling engages bladder urothelial defenses that limit urinary tract infection
Cell Reports · 2024
- Analysing the influence of dapagliflozin on urinary tract infection vulnerability and kidney injury in mice infected with uropathogenic <scp> <i>Escherichia coli</i> </scp>
Diabetes Obesity and Metabolism · 2024
- Enhancement of clinical signs in C3H/HeJ mice vaccinated with a highly immunogenic <i>Leptospira</i> methyl-accepting chemotaxis protein following challenge
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Enhancement of clinical signs in C3H/HeJ mice vaccinated with a highly immunogenic Leptospira methyl-accepting chemotaxis protein following challenge
PLoS neglected tropical diseases · 2024
- Author response for "Analysing the influence of dapagliflozin on urinary tract infection vulnerability and kidney injury in mice infected with uropathogenic <scp><i>Escherichia coli</i></scp>"
2024
- Repurposing HDAC inhibitors to enhance ribonuclease 4 and 7 expression and reduce urinary tract infection
Proceedings of the National Academy of Sciences · 2023
- Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy
European Journal of Nuclear Medicine and Molecular Imaging · 2023
- Ingesta-associated choledocholithiasis in horses: 2 cases and literature review
Journal of Veterinary Diagnostic Investigation · 2023
- Pre-clinical Evaluation of Biomarkers for Early Detection of Nephrotoxicity Following Alpha-particle Radioligand Therapy
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Optical coherence tomography for surgical margin evaluation of excised canine cutaneous and subcutaneous tumours
Veterinary and Comparative Oncology · 2022
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Journal of the American Society of Nephrology×3
- Journal of Biological Chemistry×2
- Proceedings of the National Academy of Sciences×2
- Cell Reports×1
- Laura Schwartz
Medicine · The Ohio State University
- John David Spencer
Medicine · The Ohio State University
- Juan de Dios Ruiz‐Rosado
Medicine · The Ohio State University
- Sheryl S. Justice
Medicine · The Ohio State University
- Ashley R. Jackson
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile